Ann Surg Treat Res.  2025 Jan;108(1):20-30. 10.4174/astr.2025.108.1.20.

Epidemiology and survival analysis according to the histologic subtype of pancreatic cancer: a population-based cohort study

• Park HM
• Kang MJ
• Park SJ
• Jung KW
• Han SS

• KMID: 2564239
• DOI: http://doi.org/10.4174/astr.2025.108.1.20

Abstract

Purpose
This study investigated epidemiologic features of patients with pancreatic cancer in Korea, according to the histologic subtypes.
Methods
The Korea Central Cancer Registry data on patients with pancreatic cancer from 1999 to 2019 were reviewed. The 101,446 patients with pancreatic cancer (C25 based on the International Classification of Diseases, 10th revision) were allocated according to the following morphological codes: A, endocrine; B, carcinoma excluding cystic and mucinous; C, cystic or mucinous; D, acinar cell; and E, sarcoma and soft tissue tumor.
Results
The distribution of each pancreatic cancer subtype group in Korea from 1999 to 2019 was as follows: A, n = 3,101 (3.1%); B, n = 95,051 (93.7%); C, n = 2,856 (2.8%); D, n = 299 (0.3%); and E, n = 139 (0.1%). In group B, 49.2% of patients were aged >70 years, and half of them did not receive treatment within 4 months of diagnosis. In addition, only 30.9% of the patients were in the localized and regional stage in which surgical treatment was possible. Pancreatic cancer occurred more frequently in females than in males only in group C. Between 1999 and 2019, the average annual percentage changes in the age-specific incidence rates were positive in groups A (13.9%, P < 0.001), B (1.0%, P < 0.001), and C (6.5%, P = 0.025). Significant improvements in 5-year survival rates over time were observed in subtypes A, B, and C.
Conclusion
The subgroups of pancreatic cancer show different epidemiologic features, including incidences, treatment rates, and prognoses.

Keyword

Epidemiology; Neoplasms by histologic type; Pancreatic neoplasms; Survival rate; Therapeutics